These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1252 related articles for article (PubMed ID: 26330667)
1. Personalized Medicine: Genomics Trials in Oncology. Hayes DF; Schott AF Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667 [TBL] [Abstract][Full Text] [Related]
2. Next-Generation Sequencing in Oncology in the Era of Precision Medicine. Blumenthal GM; Mansfield E; Pazdur R JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172 [No Abstract] [Full Text] [Related]
3. Delivering on the promise of precision cancer medicine. Berger MF; Van Allen EM Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852 [No Abstract] [Full Text] [Related]
4. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network. Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062 [TBL] [Abstract][Full Text] [Related]
5. Maurie Markman on the Groundbreaking TAPUR Trial. Markman M Oncology (Williston Park); 2017 Mar; 31(3):158, 168. PubMed ID: 28299751 [No Abstract] [Full Text] [Related]
6. Giving Up on Precision Oncology? Not So Fast! Warner JL Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309 [No Abstract] [Full Text] [Related]
7. New ESMO scale ranks mutations as cancer medicine targets. Fricker J Lancet Oncol; 2018 Oct; 19(10):e513. PubMed ID: 30177495 [No Abstract] [Full Text] [Related]
8. Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice. Beer PA; Cooke SL; Chang DK; Biankin AV Ann Oncol; 2019 Nov; 30(11):1691-1694. PubMed ID: 31665210 [No Abstract] [Full Text] [Related]
9. Precision medicine beyond medical oncology: using molecular analysis to guide treatments of colorectal neoplasia. Molloy MP; Engel A Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1179-1181. PubMed ID: 30791786 [No Abstract] [Full Text] [Related]
10. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology. Janiaud P; Serghiou S; Ioannidis JPA Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine. Eke I; Makinde AY; Aryankalayil MJ; Ahmed MM; Coleman CN Cancer Lett; 2016 Nov; 382(1):118-126. PubMed ID: 26828133 [TBL] [Abstract][Full Text] [Related]
12. Utilization of Genomics and Functional Genomics to Inform Clinical Decisions in IR. Schachtschneider KM; Gaba RC J Vasc Interv Radiol; 2018 Aug; 29(8):1117-1121. PubMed ID: 30055782 [No Abstract] [Full Text] [Related]
14. Cancer Genetics and Implications for Clinical Management. Jamieson NB; Chang DK; Biankin AV Surg Clin North Am; 2015 Oct; 95(5):919-34. PubMed ID: 26315514 [TBL] [Abstract][Full Text] [Related]
15. Multigene Panel Testing in Oncology Practice: How Should We Respond? Kurian AW; Ford JM JAMA Oncol; 2015 Jun; 1(3):277-8. PubMed ID: 26181167 [No Abstract] [Full Text] [Related]
16. Precision medicine in pediatric oncology. Forrest SJ; Geoerger B; Janeway KA Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430 [TBL] [Abstract][Full Text] [Related]
17. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X; Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236 [TBL] [Abstract][Full Text] [Related]